# OnCo record idea-shortened-venetoclax (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-shortened-venetoclax/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-shortened-venetoclax" ;
  schema:name "Shorter venetoclax courses in unfit AML"@en ;
  schema:description "Give venetoclax for 7 or 14 days per cycle instead of 28 to cut infections and low blood counts without losing the benefit."@en ;
  schema:url <https://onco.cc/ideas/idea-shortened-venetoclax/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2012971> ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:drugs <https://onco.cc/drugs/venetoclax/>, <https://onco.cc/drugs/azacitidine/>, <https://onco.cc/drugs/decitabine-cedazuridine/> ;
  onco:trials <https://onco.cc/trials/viale-a/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-viale-a-venetoclax-azacitidine-nejm-2020/>, <https://onco.cc/key-papers/paper-aza-aml-001-dombret-blood-2015/>, <https://onco.cc/key-papers/paper-azacitidine-aml-j-clin-oncol-2010/> .
